Edwards Lifesciences Corp. | Ownership
Companies that own Edwards Lifesciences Corp.
The Vanguard Group, Inc.
21,139,984
10.1%
178,717
0.1%
06/30/2018
BlackRock Fund Advisors
10,605,120
5.07%
-274,990
0.08%
06/30/2018
SSgA Funds Management, Inc.
8,239,993
3.94%
-137,068
0.09%
06/30/2018
Sands Capital Management LLC
6,917,432
3.3%
395,268
2.54%
06/30/2018
Fidelity Management & Research Co.
6,548,211
3.13%
1,656,393
0.1%
06/30/2018
Wellington Management Co. LLP
6,341,293
3.03%
84,074
0.17%
06/30/2018
Walter Scott & Partners Ltd.
5,115,783
2.44%
-485,467
2.02%
06/30/2018
AllianceBernstein LP
4,811,530
2.29%
-146,664
0.4%
06/30/2018
Brown Advisory LLC
3,839,628
1.83%
207,058
1.6%
06/30/2018
TIAA-CREF Investment Management LLC
3,315,251
1.58%
775,122
0.24%
06/30/2018
| Address |
One Edwards Way
Irvine California 92614
United States
|
|
Employees
|
- |
| Website |
http://www.edwards.com |
| Updated |
07/08/2019 |
| Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World. Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. |
